T8227

4-Methyl-2-oxopentanoic acid is an abnormal metabolite, a neurotoxin and a metabolic toxin.

Golocdacimab (MEDI6570) is a fully human monoclonal antibody that specifically targets the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), with research indicating potential therapeutic applications for mitigating complications associated with type 2 diabetes mellitus and for the prophylaxis of hereditary angioedema (HAE) attacks.

Gochnatiolide A is a dimeric sesquiterpene derived from plants such as Ainsliaea henryi, exhibiting significant antiproliferative activity against various cancer cell lines, including renal, melanoma, ovarian-resistant, and glioma cells.

Gnetuhainin I (Compound 5), a lignin sourced from Pouzolzia zeylanica, exhibits potent inhibition of ATP citrate lyase (ACLY) with an IC50 value of 2.63 μM [1].

GNE-235, a selective inhibitor of PBRM1's second bromodomain, exhibits a dissociation constant (K D) of 0.28 ± 0.02 μM, and can be utilized to assess the cellular function of PBRM1 [1].

GM1a Ganglioside oligosaccharide, a semisynthetic derivative of ganglioside GM1, serves as the natural receptor for cholera toxin and is crucial for both general growth regulation and the coupling of hormone-induced responses [1].

Gly-Mal-Gly-Gly-Phe-Gly-amide-methylcyclopropane-Exatecan is a compound used in the synthesis of Antibody-Drug Conjugates (ADCs) [1].